Literature DB >> 12080043

p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.

Hidetaka Uramoto1, Hiroto Izumi, Tomoko Ise, Mitsuhiro Tada, Takeshi Uchiumi, Michihiko Kuwano, Kosei Yasumoto, Keiko Funa, Kimitoshi Kohno.   

Abstract

YB-1 is a member of the cold shock domain family of proteins that is important for signaling DNA damage and cell proliferation. YB-1 is induced by DNA damage and can also recognize cisplatin-modified DNA. In this study we observed a 6-fold increase in the steady-state level of YB-1 mRNA in response to cisplatin exposure in cells of the human cancer cell line KB. We present evidence from cotransfection experiments for a critical role of c-Myc and p73 in the transactivation of the YB-1 promoter. p73 transactivated the YB-1 promoter in experiments with Saos-2 cells, which express c-Myc, but not with HO15.19 cells, which lack c-Myc. In turn, c-Myc transactivated an intact YB-1 promoter but not a YB-1 promoter with a mutant E-box, indicating that the E-box is necessary for the response of the promoter to cisplatin. We also found that p73 interacts with c-Myc in vitro and in vivo. Using deletion mutants we showed that the DNA-binding domain of p73 and the C-terminal region of c-Myc are required for the interaction. Furthermore, p73 stimulated the interaction of Max with c-Myc and promoted binding of the c-Myc-Max complex to its target DNA. Our data suggest that p73 stimulates the transcription of the YB-1 promoter by enhancing recruitment of the c-Myc-Max complex to the E-box.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080043     DOI: 10.1074/jbc.M200266200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein.

Authors:  Takao Fukuda; Megumi Ashizuka; Takanori Nakamura; Kotaro Shibahara; Katsumasa Maeda; Hiroto Izumi; Kimitoshi Kohno; Michihiko Kuwano; Takeshi Uchiumi
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

2.  Interplay between Y-box-binding protein 1 (YB-1) and poly(A) binding protein (PABP) in specific regulation of YB-1 mRNA translation.

Authors:  Dmitry N Lyabin; Irina A Eliseeva; Olga V Skabkina; Lev P Ovchinnikov
Journal:  RNA Biol       Date:  2011-07-26       Impact factor: 4.652

3.  Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.

Authors:  Andreas G Bader; Peter K Vogt
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene.

Authors:  Hiroto Izumi; Ryo Ohta; Gunji Nagatani; Tomoko Ise; Yoshifumi Nakayama; Minoru Nomoto; Kimitoshi Kohno
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 5.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

Review 6.  Inhibition of transcription by platinum antitumor compounds.

Authors:  Ryan C Todd; Stephen J Lippard
Journal:  Metallomics       Date:  2009       Impact factor: 4.526

7.  Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.

Authors:  Andreas G Bader; Katherine A Felts; Ning Jiang; Hwai Wen Chang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

8.  Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells.

Authors:  Guo-rong Wang; Yan Zheng; Xiang-ming Che; Xin-yang Wang; Jia-hui Zhao; Kai-jie Wu; Jin Zeng; Chen-en Pan; Da-lin He
Journal:  Acta Pharmacol Sin       Date:  2009-09-14       Impact factor: 6.150

9.  Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Authors:  Golareh Habibi; Samuel Leung; Jennifer H Law; Karen Gelmon; Hamid Masoudi; Dmitry Turbin; Michael Pollak; Torsten O Nielsen; David Huntsman; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2008-10-16       Impact factor: 6.466

10.  YB-1 synthesis is regulated by mTOR signaling pathway.

Authors:  Dmitry N Lyabin; Irina A Eliseeva; Lev P Ovchinnikov
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.